Local treatment of ecchymosis after combined percutaneous laser coagulation and sclerotherapy
https://doi.org/10.21518/akh2025-054
Abstract
Introduction. The combined technique of percutaneous laser photocoagulation and sclerotherapy is widely used due to its high effectiveness in eliminating telangiectasias and reticular veins. However, this technique can be accompanied by the formation of ecchymoses of varying sizes, which reduces patient comfort and satisfaction with the treatment.
Aim. To evaluate the effectiveness of a topical combined phlebotropic gel as post-procedural therapy for ecchymoses following combined sclerotherapy with transcutaneous laser coagulation of reticular veins and telangiectasias on the lower limbs.
Materials and methods. A pilot paired controlled study was conducted including 11 female patients aged 29 to 55 years (mean age 42.0 ± 9.8 years). Following combined sclerotherapy and transcutaneous laser coagulation, Detragel® was applied to one lower limb for 14 days, while the contralateral limb served as the control. The area of ecchymoses was assessed on days 3 and 17 after the procedure.
Results. By day 17, the area of ecchymosis in the topical combined phlebotropic gel group decreased from 59.1 ± 11.4 to 12.8 ± 5.4 cm², while in the control group it decreased from 61.1 ± 8.6 cm² to 31.4 ± 7.0 cm² (p < 0.001). Patient satisfaction with Detragel® treatment averaged 4.9 points, and physician satisfaction 4.2 points.
Conclusions. The use of a topical combined phlebotropic gel containing sodium heparin, essential phospholipids, and escin significantly reduces post-procedural ecchymosis area and enhances patient satisfaction with the treatment results.
About the Author
H. P. Manjikian
Eramishantsev Moscow State Hospital
Russian Federation
Russian Federation
Hovsep P. Manjikian, Cardio-Vascular Surgeon, Head of Vein Clinic, Head of Short-stay Hospital of Cardio-Vascular Surgery,
15, Lenskaya St., Moscow, 129327
References
1. Bogachev VYu, Boldin BV, Turkin PYu, Lobanov VN. Local drugs in treating and decreasing the incidence of adverse reactions after sclerotherapy of telangiectasia. Angiology and Vascular Surgery. 2019;25(4):102–107. (In Russ.) https://doi.org/10.33529/ANGIO2019405.
2. Savel’eva MI, Sychev DA. Potential of the Transdermal Drug Delivery Systems for the Topical Treatment of Chronic Venous Diseases. Flebologiya. 2018;12(1):40–49. (In Russ.) https://doi.org/10.17116/flebo201812140-49.
3. Fonseca MM, Mocelin FJ, Grill MH, Gianesini S, Miyake K, Argenta R, Pereira AH. Nd:Yag laser combined with injection sclerotherapy in the treatment of reticular veins and telangiectasias (CLaCS method): A triple-blind randomized clinical trial comparing two sclerosing agents associated with same laser patterns. Phlebology. 2023;38(3):165–171. https://doi.org/10.1177/02683555231153533.
4. Bogachev VYu, Boldin BV, Turkin PYu. Modern therapy of chronic venous disorders of the lower limbs: transdermal phlebotropic medications in focus. RMJ. 2018;(6-2):61–65. (In Russ.) Available at: https://www.rmj.ru/articles/angiologiya/Sovremennaya_terapiya_hronicheskih_zabolevaniy_ven_nighnih_konechnostey_v_fokuse_transdermalynye_flebotropnye_preparaty.
5. Wetzel D, Menke W, Dieter R, Smasal V, Giannetti B, Bulitta M. Escin/diethylammonium salicylate/heparin combination gels for the topical treatment of acute impact injuries: a randomised, double blind, placebo controlled, multicentre study. Br J Sports Med. 2002;36(3):183–188. https://doi.org/10.1136/bjsm.36.3.183.
6. Cesarone MR, Ricci A, Di Renzo A, Belcaro G, Dugall M. Efficacy of topical treatment with aescin + essential phospholipids gel on capillary fragility. Angiology. 2004;55(Suppl. 1):S23–S25. https://doi.org/10.1177/000331970405500606.
7. Gallelli L. Escin: a review of its anti-edematous, anti-inflammatory, and venotonic properties. Drug Des Devel Ther. 2019;13:3425–3437. https://doi.org/10.2147/DDDT.S207720.
8. Ilyukhin EA, Bulatov VL, Galchenko MI. Reliability and Accuracy of Measuring the Surface Area of Phantom Skin Lesions with Lesionmeter Mobile Application. Flebologiya. 2020;14(4):266–274. (In Russ.) https://doi.org/10.17116/flebo202014041266.
9. Incandela L, Belcaro G, Cesarone MR, De Sanctis MT, Griffin M. Microvascular alterations in diabetic microangiopathy: topical treatment with Essaven gel-a placebo-controlled, randomized study. Angiology. 2001;52(Suppl. 3):S35–S41. https://doi.org/10.1177/0003319701052003S08
10. Sirtori CR. Aescin: pharmacology, pharmacokinetics and therapeutic profile. Pharmacol Res. 2001;44(3):183–193. https://doi.org/10.1006/phrs.2001.0847.
11. Senin AA, Gavrilov VA, Ablyayev FK. Heparin, escin and essential phospholipids gel as part of complex therapy in the early postoperative period in patients with lower limb varicose vein disease. Ambulatornaya Khirurgiya. 2025;22(1):206–212. (In Russ.) https://doi.org/ 10.21518/akh2025-026.
Review
For citations:
Manjikian H.P. Local treatment of ecchymosis after combined percutaneous laser coagulation and sclerotherapy. Ambulatornaya khirurgiya = Ambulatory Surgery (Russia). 2025;22(2):93-96. (In Russ.) https://doi.org/10.21518/akh2025-054
Views:
16
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International.
Email this article 